Aura Biosciences Inc (AURA) Financials

$6.99

$-0.21 (-2.92%)

As on 10-Sep-2026 16:00EDT

Market cap

$784 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	-0.03	--	1.22	1.30	1.18	0.84
Gross Profit	0.03	--	-1.22	-1.30	-1.18	-0.84
Operating Expenses	138.08	112.79	96.12	83.70	60.30	35.25
Operating Profit (EBIT)	-138.08	-112.79	-96.12	-84.99	-60.30	-35.25
Other Income	--	--	--	--	1.53	0.00
Profit before Tax	-130.93	-106.08	-86.81	-76.27	-58.76	-35.25
Provision for Tax	0.08	0.11	0.11	0.14	-1.53	-0.83
Profit after Tax (Net Income)	-131.01	-106.19	-86.92	-76.41	-58.76	-35.25
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-58.76	-35.25

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	315.27	136.91	151.97	225.85	195.58	152.32
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	13.30	14.13	15.62	16.87	17.90	0.36
Current Liabilities	19.56	18.38	14.91	12.36	10.46	7.36
Total Liabilities	367.69	169.43	182.50	255.08	223.94	160.03

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	19.10	19.69	21.88	23.28	27.23	6.33
Current Assets	329.03	149.74	160.62	231.79	196.70	153.70
Total Assets	367.69	169.43	182.50	255.08	223.94	160.03
Total Debt*	16.59	17.38	18.77	19.56	20.86	0.98
Net Current Assets	309.47	131.36	145.71	219.44	186.25	146.43

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-84.74	-79.81	-63.85	-54.60	-32.41
Cash Flow from Investing Activities	--	35.60	68.82	-113.96	-67.87	-2.13
Cash from Financing Activities	--	77.16	1.60	97.29	95.63	166.26
Net Cash Inflow / Outflow	--	--	--	--	-26.84	131.72

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.80	-1.76	-1.75	-1.72	-1.84	-1.26
Cash EPS ($)	--	-1.74	-1.73	-1.69	-1.81	-1.23
Adjusted Book Value ($)	--	2.27	3.06	5.08	6.14	5.44
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.40	-1.61	-1.44	-1.71	-1.16
Free Cash Flow per Share ($)	--	-1.41	-1.63	-1.45	-1.75	-1.23

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-65.34	-41.77	-33.09	-31.79	-40.83
ROE (%)	-57.95	-73.52	-46.01	-36.26	-33.78	-41.07
ROA (%)	-44.64	-60.35	-39.73	-31.90	-30.61	-38.71
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-3,835.70	3,525,100.00
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	17.36	-22.21	-13.81	-29.79	-66.76	-58.69
Net Profit Growth (%)	-29.23	-22.17	-13.76	-30.03	-66.70	-58.75
EPS Growth (%)	8.05	-0.01	-0.02	0.07	-0.47	-0.11
Book Value Growth (%)	10.41	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-3.10	-4.70	-5.15	-5.69	-13.49
Price / Book Value	2.44	2.40	2.69	1.74	1.71	3.12
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-5.68	-1.92	-3.22	-2.50	-2.89	-9.52
Close Price ($)	7.10	5.45	8.22	8.86	10.50	16.98
High Price ($)	9.54	8.60	12.38	13.50	24.83	26.16
Low Price ($)	4.84	4.35	6.63	5.99	9.43	13.50
Market Cap ($ Cr)	784.01	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.13	0.12	0.09	0.11	0.01
Short term debt to equity ratio	0.01	0.02	0.02	0.01	0.02	0.00
Current Ratio	16.82	8.15	10.77	18.76	18.81	20.90
Quick Ratio	16.82	--	--	--	--	--
Interest Coverage	--	--	--	--	-69.13	-2,710.62

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	610.89	663.94	825.77	658.76
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.